dan 2163 has been researched along with Psychoses in 75 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amisulpride was more efficacious than aripiprazole or olanzapine for reducing the PANSS total scores in adults with schizophrenia-spectrum disorders." | 9.34 | Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial. ( Alisauskiene, R; Anda, LG; Bartz-Johannessen, C; Berle, JØ; Bjarke, J; Fathian, F; Fleischhacker, WW; Hugdahl, K; Joa, I; Johnsen, E; Kjelby, E; Kroken, RA; Larsen, TK; Løberg, EM; Reitan, SK; Rettenbacher, M; Sinkeviciute, I; Skrede, S; Stabell, L; Steen, VM; Walla, B, 2020) |
| "Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride." | 9.12 | Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. ( Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT, 2007) |
| "Amisulpride was more efficacious than aripiprazole or olanzapine for reducing the PANSS total scores in adults with schizophrenia-spectrum disorders." | 5.34 | Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial. ( Alisauskiene, R; Anda, LG; Bartz-Johannessen, C; Berle, JØ; Bjarke, J; Fathian, F; Fleischhacker, WW; Hugdahl, K; Joa, I; Johnsen, E; Kjelby, E; Kroken, RA; Larsen, TK; Løberg, EM; Reitan, SK; Rettenbacher, M; Sinkeviciute, I; Skrede, S; Stabell, L; Steen, VM; Walla, B, 2020) |
| "The study was designed as a 6-week, two-center, fixed-dose, comparison study of 400 mg/day of amisulpride versus 300 mg/day of moclobemide as an adjunctive treatment in 53 schizophrenia and schizoaffective disorder patients (diagnosed according to DSM-IV) suffering from CIS." | 5.15 | Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation. ( Bergman, J; Kreinin, A; Lerner, V; Libov, I; Miodownik, C; Shestakova, D; Sokolik, S, 2011) |
| "To compare the effects of haloperidol, amisulpride, olanzapine, quetiapine, and ziprasidone on hostility in first-episode schizophrenia, schizoaffective disorder, or schizophreniform disorder." | 5.15 | Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). ( Bitter, I; Czobor, P; Derks, EM; Fleischhacker, WW; Kahn, RS; Libiger, J; Volavka, J, 2011) |
| "Both amisulpride and olanzapine produce sustained improvement in certain measures of neuropsychological performance in patients with schizophrenia; a significant improvement in score on the AVLT was observed only with amisulpride." | 5.12 | Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. ( Balasubramaniam, K; Choudhary, PC; Joyce, E; Mortimer, AM; Saleem, PT, 2007) |
| " Furthermore, this case suggests that changing the regimen to aripiprazole with propranolol may be a potential option for amisulpride withdrawal akathisia superimposed on pre-existing hyperprolactinemia." | 4.12 | Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report. ( Kim, SG; Seo, EH; Yang, HJ; Yoon, HJ, 2022) |
| " The authors present a case of amisulpiride-induced catatonia, further evaluation suggested neuroleptic malignant syndrome (NMS) and showed the occurrence of temporal lobe epilepsy (TLE) and underlying brain pathology with marked frontoparietal atrophy and periventricular white matter hyperintensities." | 3.75 | Catatonia, neuroleptics and brain damage--a case report. ( Chandran, M; El-Shazly, M, 2009) |
| "Psychotic depression is classified as a clinical subtype of major depressive disorder." | 2.73 | Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression. ( Papadimitriou, GN; Politis, AM; Psarros, C; Soldatos, CR; Theleritis, CG, 2008) |
| "22 patients (8 manic-depressive psychoses and 14 schizophrenias) were given sultopride as the sole therapy, in a daily dose of 4 vials." | 2.65 | [Longterm psychosis and sultopride]. ( Morel, D, 1983) |
| "Treatment with Lamotrigine and Amisulpiride achieved an excellent response, and she has remained symptom free for 7 months." | 2.48 | Temporal lobe epilepsy masquerading as psychosis--a case report and literature review. ( Hamelijnck, J; Needham, E, 2012) |
| "Even though akathisia is less prevalent with SGAs than with the first-generation drugs, it remains clinically important and all clinicians should be conversant with its recognition and management." | 2.45 | Akathisia and second-generation antipsychotic drugs. ( Kumar, R; Sachdev, PS, 2009) |
| " Amisulpride shows linear pharmacokinetics, a bioavailability of 48%, low protein binding (17%) and an elimination half-life of approximately 12 h." | 2.41 | A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. ( Bergougnan, L; Bianchetti, G; Canal, M; Patat, A; Rosenzweig, P; Zieleniuk, I, 2002) |
| "Schizoaffective disorder is listed in the category "schizophrenia and other psychotic disorders"." | 2.41 | [Schizoaffective disorder: clinical symptoms and present-day approach to treatment]. ( Danileviciūte, V, 2002) |
| "Risperidone appears to be an effective therapy, but several authors report cases of TD during treatment." | 2.41 | Tardive dyskinesias and antipsychotics: a review. ( Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM, 2002) |
| " Model predictions were used to simulate dose-response and dose-EPS." | 1.46 | A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease. ( Bertrand, J; Brownings, S; D'Antonio, F; Dunn, JT; Greaves, S; Howard, R; Kessler, R; Marsden, P; McLachlan, E; Nair, A; Reeves, S; Smith, A; Taylor, D; Uchida, H, 2017) |
| "Acute psychosis is diagnosed by clearly defined operational criteria embedded into international classification systems." | 1.36 | Gender, psychosis and psychotropic drugs: differences and similarities. ( Groleger, U; Novak-Grubic, V, 2010) |
| "Aripiprazole is a new generation antipsychotic drug with a partial agonist effect on dopamine D2 and D3 receptors." | 1.35 | Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. ( Adan-Manes, J; Garcia-Parajua, P, 2009) |
| " No significant correlation was detected between prolactin levels and either amisulpride dosage or duration of administration." | 1.34 | Amisulpride-induced hyperprolactinemia is reversible following discontinuation. ( Liappas, J; Mourikis, I; Paparrigopoulos, T; Soldatos, C; Tzavellas, E, 2007) |
| " However, no correlation between prolactin levels and dosage could be found." | 1.32 | [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics]. ( Fric, M; Laux, G, 2003) |
| "Ten adolescent cases are presented with regard to the efficacy, side effects and dosage of amisulpride." | 1.31 | [Initial experiences with amisulpride, an in Germany novel, atypical neuroleptic drug in treatment of adolescents with psychiatric disorders]. ( Göpel, C; Marcus, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (6.67) | 18.7374 |
| 1990's | 1 (1.33) | 18.2507 |
| 2000's | 37 (49.33) | 29.6817 |
| 2010's | 25 (33.33) | 24.3611 |
| 2020's | 7 (9.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, HJ | 1 |
| Kim, SG | 1 |
| Seo, EH | 1 |
| Yoon, HJ | 1 |
| Jannini, TB | 1 |
| Sansone, A | 1 |
| Rossi, R | 1 |
| Di Lorenzo, G | 1 |
| Toscano, M | 1 |
| Siracusano, A | 1 |
| Jannini, EA | 1 |
| Luykx, JJ | 3 |
| Kraats, GV | 1 |
| van Ojen, R | 1 |
| Levi, L | 1 |
| Bar Haim, M | 1 |
| Burshtein, S | 1 |
| Winter-Van Rossum, I | 3 |
| Heres, S | 2 |
| Davidson, M | 1 |
| Shenkman, G | 1 |
| Kahn, RS | 9 |
| Weiser, M | 1 |
| Ter Hark, SE | 2 |
| Jamain, S | 2 |
| Schijven, D | 1 |
| Lin, BD | 1 |
| Bakker, MK | 1 |
| Boland-Auge, A | 2 |
| Deleuze, JF | 2 |
| Troudet, R | 2 |
| Malhotra, AK | 1 |
| Gülöksüz, S | 2 |
| Vinkers, CH | 2 |
| Ebdrup, BH | 4 |
| Leboyer, M | 3 |
| Baandrup, L | 1 |
| Allerup, P | 1 |
| Nielsen, MØ | 2 |
| Bak, N | 1 |
| Düring, SW | 1 |
| Leucht, S | 3 |
| Galderisi, S | 2 |
| Mucci, A | 2 |
| Bucci, P | 2 |
| Arango, C | 2 |
| Díaz-Caneja, CM | 1 |
| Dazzan, P | 1 |
| McGuire, P | 3 |
| Demjaha, A | 1 |
| Glenthøj, BY | 1 |
| Ali, WBH | 1 |
| Bacq-Daian, D | 1 |
| Rossum, IWV | 1 |
| Battail, C | 1 |
| Barau, C | 1 |
| Rujescu, D | 2 |
| Johnsen, E | 1 |
| Kroken, RA | 1 |
| Løberg, EM | 1 |
| Rettenbacher, M | 1 |
| Joa, I | 1 |
| Larsen, TK | 1 |
| Reitan, SK | 1 |
| Walla, B | 1 |
| Alisauskiene, R | 1 |
| Anda, LG | 1 |
| Bartz-Johannessen, C | 1 |
| Berle, JØ | 1 |
| Bjarke, J | 1 |
| Fathian, F | 1 |
| Hugdahl, K | 1 |
| Kjelby, E | 1 |
| Sinkeviciute, I | 1 |
| Skrede, S | 1 |
| Stabell, L | 1 |
| Steen, VM | 1 |
| Fleischhacker, WW | 4 |
| Reeves, S | 6 |
| McLachlan, E | 3 |
| Bertrand, J | 3 |
| D'Antonio, F | 2 |
| Brownings, S | 4 |
| Nair, A | 3 |
| Greaves, S | 4 |
| Smith, A | 3 |
| Taylor, D | 4 |
| Dunn, J | 2 |
| Marsden, P | 4 |
| Kessler, R | 4 |
| Howard, R | 6 |
| Eggleston, K | 1 |
| Cort, E | 3 |
| Dunn, JT | 2 |
| Uchida, H | 1 |
| Barrimi, M | 1 |
| El Ghazouani, F | 1 |
| Zaimi, O | 1 |
| Oneib, B | 1 |
| Bradley, R | 2 |
| Harper, E | 2 |
| Kelly, L | 2 |
| Bentham, P | 2 |
| Ritchie, C | 2 |
| Fawzi, W | 2 |
| Livingston, G | 2 |
| Sommerlad, A | 2 |
| Oomman, S | 2 |
| Nazir, E | 2 |
| Nilforooshan, R | 2 |
| Barber, R | 2 |
| Fox, C | 2 |
| Macharouthu, AV | 1 |
| Ramachandra, P | 3 |
| Pattan, V | 2 |
| Sykes, J | 2 |
| Curran, V | 2 |
| Katona, C | 2 |
| Dening, T | 2 |
| Knapp, M | 2 |
| Gray, R | 2 |
| Zipursky, RB | 1 |
| Sommer, IE | 2 |
| Heriot-Maitland, C | 1 |
| Allan, S | 1 |
| Bradstreet, S | 1 |
| Gumley, A | 1 |
| Macharouthu, A | 1 |
| Romeo, R | 1 |
| Pandit, R | 1 |
| Cianci, D | 1 |
| Broberg, BV | 1 |
| Garcia-Portilla, MP | 1 |
| Bobes, J | 1 |
| Huitema, ADR | 1 |
| Bernacer, J | 1 |
| Corlett, PR | 1 |
| McFarlane, B | 1 |
| Turner, DC | 1 |
| Clark, L | 1 |
| Robbins, TW | 1 |
| Fletcher, PC | 1 |
| Murray, GK | 1 |
| Clark-Papasavas, C | 1 |
| Mogg, A | 1 |
| Gomes, R | 1 |
| Liu, K | 1 |
| Nwosu, B | 1 |
| Joemon, J | 1 |
| Cleij, M | 1 |
| Seeman, P | 1 |
| Glenthøj, B | 2 |
| Leweke, FM | 1 |
| Lewis, S | 1 |
| Meyer-Lindenberg, A | 1 |
| Kapur, S | 2 |
| Raghava, JM | 1 |
| Rostrup, E | 1 |
| Bas, A | 1 |
| Gultekin, G | 1 |
| Incir, S | 1 |
| Bas, TO | 1 |
| Emul, M | 1 |
| Duran, A | 1 |
| Chandran, M | 1 |
| El-Shazly, M | 1 |
| Müller, MJ | 1 |
| Eich, FX | 1 |
| Regenbogen, B | 1 |
| Sachse, J | 1 |
| Härtter, S | 1 |
| Hiemke, C | 1 |
| Meisenzahl, EM | 1 |
| Schmitt, G | 1 |
| Gründer, G | 1 |
| Dresel, S | 1 |
| Frodl, T | 1 |
| la Fougère, C | 1 |
| Scheuerecker, J | 1 |
| Schwarz, M | 1 |
| Boerner, R | 1 |
| Stauss, J | 1 |
| Hahn, K | 1 |
| Möller, HJ | 2 |
| Adan-Manes, J | 1 |
| Garcia-Parajua, P | 1 |
| Varol Tas, F | 1 |
| Guvenir, T | 1 |
| Kumar, R | 1 |
| Sachdev, PS | 1 |
| Crespo-Facorro, B | 1 |
| Rodríguez-Sánchez, JM | 1 |
| Pérez-Iglesias, R | 1 |
| Mata, I | 1 |
| Ayesa, R | 1 |
| Ramirez-Bonilla, M | 1 |
| Martínez-Garcia, O | 1 |
| Vázquez-Barquero, JL | 1 |
| Sparshatt, A | 1 |
| Patel, MX | 1 |
| Rizos, E | 1 |
| Douzenis, A | 1 |
| Gournellis, R | 1 |
| Christodoulou, C | 1 |
| Lykouras, LP | 1 |
| Bakhla, AK | 1 |
| Goyal, N | 1 |
| Nizamie, SH | 1 |
| Höfer, P | 1 |
| Friedrich, F | 1 |
| Vyssoki, B | 1 |
| Spindelegger, C | 1 |
| Schmook, M | 1 |
| Barnas, C | 1 |
| Lesch, OM | 1 |
| Walter, H | 1 |
| Groleger, U | 1 |
| Novak-Grubic, V | 1 |
| Chen, JH | 1 |
| Tzeng, NS | 1 |
| Kreinin, A | 1 |
| Miodownik, C | 1 |
| Sokolik, S | 1 |
| Shestakova, D | 1 |
| Libov, I | 1 |
| Bergman, J | 1 |
| Lerner, V | 1 |
| Moons, T | 1 |
| Claes, S | 1 |
| Martens, GJ | 1 |
| Peuskens, J | 1 |
| Van Loo, KM | 1 |
| Van Schijndel, JE | 1 |
| De Hert, M | 1 |
| van Winkel, R | 1 |
| Volavka, J | 1 |
| Czobor, P | 1 |
| Derks, EM | 1 |
| Bitter, I | 2 |
| Libiger, J | 2 |
| Needham, E | 1 |
| Hamelijnck, J | 1 |
| Rosenzweig, P | 1 |
| Canal, M | 1 |
| Patat, A | 1 |
| Bergougnan, L | 1 |
| Zieleniuk, I | 1 |
| Bianchetti, G | 1 |
| Danileviciūte, V | 1 |
| Fric, M | 1 |
| Laux, G | 1 |
| Wagenpfeil, S | 1 |
| Hamann, J | 1 |
| Kissling, W | 1 |
| Zink, M | 1 |
| Henn, FA | 1 |
| Thome, J | 1 |
| Bressan, RA | 1 |
| Erlandsson, K | 1 |
| Spencer, EP | 2 |
| Ell, PJ | 1 |
| Pilowsky, LS | 1 |
| Bergemann, N | 2 |
| Kopitz, J | 2 |
| Kress, KR | 2 |
| Frick, A | 2 |
| Agelink, MW | 1 |
| Kavuk, I | 1 |
| Ak, I | 1 |
| Jagadheesan, K | 1 |
| Muirhead, D | 1 |
| Stahl, S | 1 |
| Freudenreich, O | 1 |
| Goff, D | 1 |
| Bliesener, N | 1 |
| Yokusoglu, H | 1 |
| Quednow, BB | 1 |
| Klingmüller, D | 1 |
| Kühn, KU | 2 |
| Taylor, M | 1 |
| Turner, M | 1 |
| Watt, L | 1 |
| Brown, D | 1 |
| Martin, M | 1 |
| Fraser, K | 1 |
| Saft, C | 1 |
| Andrich, J | 1 |
| Kraus, PH | 1 |
| Przuntek, H | 1 |
| Paparrigopoulos, T | 1 |
| Liappas, J | 1 |
| Tzavellas, E | 1 |
| Mourikis, I | 1 |
| Soldatos, C | 1 |
| Lecrubier, Y | 1 |
| Quintin, P | 1 |
| Bouhassira, M | 1 |
| Perrin, E | 1 |
| Lancrenon, S | 1 |
| Murphy, BP | 1 |
| Stuart, AH | 1 |
| Wade, D | 1 |
| Cotton, S | 1 |
| McGorry, PD | 1 |
| Lim, HK | 1 |
| Pae, CU | 1 |
| Lee, C | 1 |
| Lee, CU | 1 |
| Bret, MC | 1 |
| Bret, P | 1 |
| Pariente, A | 1 |
| Fourier-Réglat, A | 1 |
| Mortimer, AM | 1 |
| Joyce, E | 1 |
| Balasubramaniam, K | 1 |
| Choudhary, PC | 1 |
| Saleem, PT | 1 |
| Gibbs, AA | 1 |
| Naudts, KH | 1 |
| David, AS | 1 |
| Ruhrmann, S | 1 |
| Bechdolf, A | 1 |
| Wagner, M | 1 |
| Schultze-Lutter, F | 1 |
| Janssen, B | 1 |
| Maurer, K | 1 |
| Häfner, H | 1 |
| Gaebel, W | 1 |
| Maier, W | 1 |
| Klosterkötter, J | 1 |
| Yalcin, DO | 1 |
| Goka, E | 1 |
| Aydemir, MC | 1 |
| Kisa, C | 1 |
| Politis, AM | 1 |
| Papadimitriou, GN | 1 |
| Theleritis, CG | 1 |
| Psarros, C | 1 |
| Soldatos, CR | 1 |
| Morel, D | 2 |
| Miyachi, Y | 1 |
| Mizuchi, A | 1 |
| Hamano, H | 1 |
| Sarai, K | 1 |
| Olie, JP | 1 |
| Ghaoui, S | 1 |
| Bayle, FJ | 2 |
| Jatzko, A | 1 |
| Ries, S | 1 |
| Schreiner, A | 1 |
| Braus, DF | 1 |
| Göpel, C | 1 |
| Marcus, A | 1 |
| Llorca, PM | 1 |
| Chereau, I | 1 |
| Lancon, C | 1 |
| Richou, H | 1 |
| Hug, R | 1 |
| Haumonte, MT | 1 |
| Hoffmann, E | 1 |
| Koriche, A | 1 |
| Vallindra, C | 1 |
| Gaume, JY | 1 |
| Leser, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Bergen Psychosis Project 2 - The Bergen-Stavanger-Innsbruck-Trondheim Study[NCT01446328] | Phase 4 | 151 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| Comparison of Benzamide Derivates (Amisulpride, Moclobemide and Tiapride) as Treatment of Clozapine-induced Hypersalivation: Pilot Double Phase Study: Open and Double-blind[NCT00534573] | Phase 3 | 54 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| Effectiveness of the RemedRugby Program, a Program of Ecological Cognitive Remediation of Social Cognition Disorders in Schizophrenia[NCT03775564] | 60 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| Therapy With Bromocriptine in Patients With Symptomatic Risperidone-Induced Hyperprolactinemia[NCT00315081] | Phase 3 | 20 participants | Interventional | 2006-05-31 | Not yet recruiting | ||
| Dopamine D2/3- and μ-opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity in Healthy Volunteers[NCT02557984] | 121 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for dan 2163 and Psychoses
| Article | Year |
|---|---|
Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Humans; Male; Psychotic Disorders; Risperidone; Sex | 2022 |
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clinical Trials | 2015 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Hum | 2009 |
Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Drug Monitoring | 2009 |
Temporal lobe epilepsy masquerading as psychosis--a case report and literature review.
Topics: Adult; Amisulpride; Anticonvulsants; Antipsychotic Agents; Diagnosis, Differential; Epilepsy, Tempor | 2012 |
A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.
Topics: Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dopamine; Electroencephalography; Human | 2002 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic | 2002 |
[New antipsychotic agents].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazole | 1999 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Ola | 2002 |
26 trials available for dan 2163 and Psychoses
| Article | Year |
|---|---|
Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Cohort Studies; Double-Blind Method; Europe; F | 2020 |
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Midd | 2020 |
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Dopamine | 2017 |
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.
Topics: Age of Onset; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Double-Blind Method; Femal | 2018 |
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
Topics: Aged; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Double-Blind Method; Englan | 2018 |
Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort).
Topics: Adult; Age Factors; Amisulpride; Antipsychotic Agents; Cohort Studies; Europe; Female; Humans; Male; | 2019 |
Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Comorbid | 2009 |
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dose-Response Relationship, D | 2008 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Fe | 2009 |
Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Clozapine; Cross-Over Studies; Female; Humans; Male; | 2011 |
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Haloperid | 2011 |
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzot | 2013 |
Amisulpride is an "atypical" antipsychotic associated with low weight gain.
Topics: Amisulpride; Antipsychotic Agents; Databases as Topic; Dose-Response Relationship, Drug; Humans; Mal | 2004 |
Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Age Factors; Amisulpride; Antipsychotic Agents; Biomimetics; Chromatography, High | 2004 |
Clozapine with amisulpride for refractory schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Drug Therapy, C | 2004 |
Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bromocriptine; Estradiol; Female; Follicle Stimulating Hor | 2004 |
Amisulpride has no effect on plasma clozapine concentrations.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Combinations; Drug Interactions; Female; H | 2005 |
The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.
Topics: Adult; Affect; Amisulpride; Antipsychotic Agents; Attention; Basal Ganglia Diseases; Benzodiazepines | 2006 |
Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Male; Neuropsychological Tests | 2006 |
Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Behavioral Symptoms; | 2006 |
Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dose- | 2007 |
The role of dopamine in attentional and memory biases for emotional information.
Topics: Adolescent; Adult; Amisulpride; Attention; Dopamine; Dopamine Antagonists; Emotions; Humans; Male; M | 2007 |
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Combined Modality Therapy; Drug Administration | 2007 |
Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
Topics: Aged; Aged, 80 and over; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depression; Drug | 2008 |
[Longterm psychosis and sultopride].
Topics: Adult; Amisulpride; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Ps | 1983 |
[Early infantile psychoses and sultopride].
Topics: Adult; Amisulpride; Clinical Trials as Topic; Humans; Male; Psychotic Disorders; Psychotropic Drugs; | 1982 |
40 other studies available for dan 2163 and Psychoses
| Article | Year |
|---|---|
Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benztropine; Female; Humans; Hyperprolactine | 2022 |
[Amisulpride, a one-of-a-kind and highly efficacious antipsychotic agent in the treatment of first-episode psychosis].
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Monitoring; Drug Substitution; Humans; Olanzapine | 2019 |
A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).
Topics: Adult; Alleles; Amisulpride; Antipsychotic Agents; Cohort Studies; Female; Genetic Loci; Genome-Wide | 2020 |
Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Behavioral Symptoms; Female; Humans; Male; Middle Aged; Ps | 2020 |
Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychoses.
Topics: Amisulpride; Antipsychotic Agents; Europe; Gene Expression; Humans; Psychotic Disorders; Treatment O | 2020 |
Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Female; Humans; Male; | 2018 |
A Population Approach to Guide Amisulpride Dose Adjustments in Older Patients With Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Basal Ganglia Diseases; Brain; Delusions; D | 2017 |
[Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Female; Humans; Neuroleptic Malignant Syndr | 2018 |
Rapid remission of first-episode schizophrenia with standardised treatment.
Topics: Amisulpride; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Antipsychotic treatments: who is really failing here? - Authors' reply.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Antipsychotic treatments: who is really failing here?
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms.
Topics: Adult; Amisulpride; Antipsychotic Agents; Basal Ganglia; Central Nervous System Stimulants; Corpus S | 2013 |
Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Brain Map | 2014 |
Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's disease.
Topics: Alzheimer Disease; Amisulpride; Antipsychotic Agents; Benzamides; Brain Mapping; Female; Humans; Mal | 2014 |
Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
Topics: Acute Disease; Adult; Amisulpride; Anisotropy; Antipsychotic Agents; Brain; Diffusion Magnetic Reson | 2016 |
Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Female; Humans; Mal | 2017 |
Catatonia, neuroleptics and brain damage--a case report.
Topics: Amisulpride; Antipsychotic Agents; Atrophy; Catatonia; Epilepsy, Temporal Lobe; Female; Frontal Lobe | 2009 |
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Topics: Amisulpride; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Biperiden; Dopamine; Drug T | 2009 |
Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders.
Topics: Adolescent; Amisulpride; Antiparkinson Agents; Antipsychotic Agents; Biperiden; Dose-Response Relati | 2009 |
Tardive dyskinesia in a patient treated with quetiapine.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskine | 2009 |
Amisulpride-induced mania with interictal psychosis.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Psychotic Disorders; | 2009 |
Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Hyperprolacti | 2010 |
Gender, psychosis and psychotropic drugs: differences and similarities.
Topics: Acute Disease; Adult; Affect; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Dose-Respon | 2010 |
Successful treatment with amisulpride for poststroke psychosis.
Topics: Amisulpride; Antipsychotic Agents; Female; Humans; Middle Aged; Psychotic Disorders; Stroke; Sulpiri | 2010 |
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodi | 2011 |
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiaze | 2003 |
Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Drug Therapy, Combinatio | 2004 |
Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brain; Contrast Media; Dopamine D2 Receptor Antagonists; D | 2004 |
Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
Topics: Aged; Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Humans; Male; M | 2004 |
A successful antipsychotic combination trial. Quo Vadis?
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Drug Therapy, Combination; Humans; Psy | 2004 |
Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiaz | 2005 |
[Amisulpride in Huntington's disease].
Topics: Aged; Amisulpride; Antipsychotic Agents; Delusions; Dose-Response Relationship, Drug; Drug Administr | 2005 |
Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Hy | 2007 |
The use of atypical antipsychotics in French psychiatric hospitals.
Topics: Adult; Age Factors; Amisulpride; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Benzo | 2007 |
Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Blood Cell Count; Dibenzothiazepines; Female | 2008 |
Effects of chronic sultopride treatment on endocrine systems in psychotic women.
Topics: Adult; Amisulpride; Chronic Disease; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone | 1984 |
[Acute tongue and pharyngeal spasms during changeover from clozapine to amisulpride. A case example].
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dr | 2000 |
[Initial experiences with amisulpride, an in Germany novel, atypical neuroleptic drug in treatment of adolescents with psychiatric disorders].
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Drug Adminis | 2001 |
[Sultopride in a day hospital].
Topics: Amisulpride; Bipolar Disorder; Day Care, Medical; Hospitals, Psychiatric; Humans; Male; Mental Disor | 1979 |
[The role of a mediator object in the initial analytic therapy of psychotics].
Topics: Amisulpride; Antipsychotic Agents; Combined Modality Therapy; Humans; Psychoanalytic Therapy; Psycho | 1986 |